Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GRCE
GRCE logo

GRCE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GRCE News

Grace Therapeutics Reports FY 2026 Financial Results and NDA Update

Jun 22 2026NASDAQ.COM

Grace Therapeutics Under Investigation for Securities Violations

Jun 08 2026PRnewswire

Pomerantz LLP Investigates Claims for Grace Therapeutics Investors

May 21 2026PRnewswire

Pomerantz LLP Investigates Grace Therapeutics for Securities Fraud

May 15 2026PRnewswire

Grace's Drug FDA Rejection Leads to Stock Plunge

Apr 24 2026stocktwits

Grace Therapeutics Faces FDA Rejection for New Drug Application

Apr 24 2026NASDAQ.COM

FDA Rejects Grace Therapeutics Drug Application

Apr 23 2026stocktwits

FDA Issues Complete Response Letter for GTx-104 Application

Apr 23 2026Newsfilter

GRCE Events

06/18 16:30
Major Averages Rebound, Nasdaq Gains 1.91%
The major averages closed broadly higher in a rebound from the prior session's selloff after the Federal Reserve held rates steady but signaled that a rate hike later this year remains possible. Meanwhile, oil prices declined after President Donald Trump signed a memorandum of understanding with Iran's President Masoud Pezeshkian to end the war and open the Straight of Hormuz.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:President Trump said Applehaswith Intelto design chipsApple CEO Tim Cookthe company will raise prices on its products to offset increasing memory and storage costsAccenturereportedand narrowed its FY26 earnings guidanceKrogerreportedand reaffirmed its FY26 outlookRumbleannounced a2. WALL STREET CALLS:Aretecoverage of SpaceXwith a Buy rating and Street-high $401 price targetSalesforceto Buy at Monness CrespiIntuitto Hold at StifelenGeneto Underweight at Morgan StanleyBarclaysEnphaseto Equal Weight on data center opportunity3. AROUND THE WEB:SpaceXbankers are preparing a $20B bond offering, Bloomberg reportsVail Resortsis working with takeover-defense bankers, Semafor saysSamsungis seeing a rise in advanced chip production requests from BYD, Google, AMD, Tesla, and other companies as AI demand strains TSMC'scapacity, Nikkei Asia reportsThe U.S. Federal Trade Commission, FTC, has drafted a potential complaint against Amazonover claims the company misled advertisers, Bloomberg reportsCME Groupsued the Commodity Futures Trading Commission over the regulator allowing perpetual futures tied to the price of cryptocurrencies, Bloomberg says4. MOVERS:Butterfly Networkgained after commenting on Midjourney'sSmith & Wesson Brandswas higher afterMarvellwas up after announcing it has shipped overwith Tower SemiconductorNovocurewas lower in New York after announcing its Phase 3 TRIDENT trialLegend Biotechfell after announcing a5. EARNINGS/GUIDANCE:Deluxereaffirmed itsGrace TherapeuticsreportedSagtecprovidedSteel DynamicsprovidedNucorprovided itsINDEXES:The Dow rose 72.15, or 0.14%, to 51,564.70, the Nasdaq gained 496.28, or 1.91%, to 26,517.93, and the S&P 500 advanced 80.48, or 1.08%, to 7,500.58.
06/18 12:30
Major Averages Rebound, Nasdaq Up 1.28%
The major averages were broadly higher near noon in a rebound from the prior session's selloff after the Federal Reserve held rates steady but signaled that a rate hike later this year remains possible, prompting renewed concern about inflation and the outlook for monetary policy. Meanwhile, oil prices have declined after President Donald Trump signed a memorandum of understanding with Iran's President Masoud Pezeshkian to end the war. Since the signing of the MOU, three supertankers from Saudi Arabia carrying 6M oil barrels have crossed the Strait of Hormuz.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:President Trump said Applewith Intelto design chipsApple CEO Tim Cookthe company will raise prices on its products to offset increasing memory and storage costsAccenturereportedand narrowed its FY26 earnings guidanceKrogerreportedand reaffirmed its FY26 outlookRumbleannounced a2. WALL STREET CALLS:Areteof SpaceXwith a Buy rating and Street-high $401 price targetSalesforceto Buy at Monness CrespiIntuitto Hold at StifelenGeneto Underweight at Morgan StanleyBarclaysEnphaseto Equal Weight on data center opportunity3. AROUND THE WEB:Metahas shifted from opposing to supporting the Kids Online Safety Act after the bill was paired with provisions that would preempt state AI regulations and require app stores operated by Googleand Appleto verify users' ages, Politico saysSamsungis seeing a rise in advanced chip production requests from BYD, Google, AMD, Tesla, and other companies as AI demand strains TSMC'scapacity, Nikkei Asia reportsJPMorganChase has cut off its Hong Kong staff from accessing Anthropic's AI models, FT saysThe U.S. Federal Trade Commission, FTC, has drafted a potential complaint against Amazonover claims the company misled advertisers, Bloomberg reportsCME Groupsued the Commodity Futures Trading Commission and its Chairman Michael Selig over the regulator allowing perpetual futures tied to the price of cryptocurrencies, Bloomberg says4. MOVERS:Butterfly Networkgains after commenting onSmith & Wesson Brandshigher afterMarvellup after announcing it hascoherent photonic integrated circuits with Tower SemiconductorNovocurelower in New York after announcing itsdid not meet its primary endpointLegend Biotechfalls after announcing a5. EARNINGS/GUIDANCE:Deluxefor FY26Grace TherapeuticsSagtecSteel DynamicsNucorfor Q2INDEXES:Near midday, the Dow was up 0.30%, or 154.10, to 51,646.65, the Nasdaq was up 1.28%, or 333.38, to 26,355.03, and the S&P 500 was up 0.96%, or 71.37, to 7,491.47.
06/18 08:30
Grace Therapeutics CEO Says FDA Application Will Bring First Innovation in 40 Years
"Since receipt of the U.S. Food and Drug Administration's (FDA) Complete Response Letter in April 2026, we have been working diligently on addressing the cited items, and we look forward to a constructive discussion with the FDA as we continue to prepare our resubmission," said Prashant Kohli, CEO of Grace Therapeutics. "FDA approval of our New Drug Application for GTx-104 for the treatment of aSAH would represent the first meaningful innovation in the standard of care for these patients in more than 40 years. As evidenced by the response among researchers, practitioners and industry leaders to the presentation of our Phase 3 STRIVE-ON trial results at major medical conferences throughout the fiscal year, we believe there is a significant desire in the marketplace for an intravenously administered nimodipine. We are confident in the robust data package supporting our NDA, and that the issues identified by the FDA can be successfully addressed in our resubmission."
05/12 08:50
Significant Increases in Indicative Borrow Rates for Liquid Options
Latest data shows the largest indicative borrow rate increases among liquid option names include: Pluralsight Inc (PS) 290.72% +39.91, Grace Therapeutics, Inc (GRCE) 6.95% +4.26, Serve Robotics Inc (SERV) 22.60% +4.25, SoundHound AI (SOUN) 34.54% +3.04, T-REX 2X LONG MSTR DAILY TARGET (MSTU) 19.75% +2.07, T-REX 2X Long BMNR Daily Target ETF (BMNU) 16.49% +1.98, BigBearai Holdings (BBAI) 3.80% +1.89, Kodiak AI, Inc. Common Stock (KDK) 86.11% +1.08, Bilibili (BILI) 3.61% +1.01, and Tradr 2X Long QBTS Daily ETF (QBTX) 30.40% +1.00.

GRCE Monitor News

FDA Issues Complete Response Letter for Grace Therapeutics' GTx-104

Apr 23 2026

GRCE Earnings Analysis

No Data

No Data

People Also Watch